Haplotype analysis reveals a possible founder effect of RET mutation R114H for Hirschsprung's disease in the Chinese population
- PMID: 20532249
- PMCID: PMC2880000
- DOI: 10.1371/journal.pone.0010918
Haplotype analysis reveals a possible founder effect of RET mutation R114H for Hirschsprung's disease in the Chinese population
Abstract
Background: Hirschsprung's disease (HSCR) is a congenital disorder associated with the lack of intramural ganglion cells in the myenteric and sub-mucosal plexuses along varying segments of the gastrointestinal tract. The RET gene is the major gene implicated in this gastrointestinal disease. A highly recurrent mutation in RET (RET(R114H)) has recently been identified in approximately 6-7% of the Chinese HSCR patients which, to date, has not been found in Caucasian patients or controls nor in Chinese controls. Due to the high frequency of RET(R114H) in this population, we sought to investigate whether this mutation may be a founder HSCR mutation in the Chinese population.
Methodology and principal findings: To test whether all RET(R114) were originated from a single mutational event, we predicted the approximate age of RET(R114H) by applying a Bayesian method to RET SNPs genotyped in 430 Chinese HSCR patients (of whom 25 individuals had the mutation) to be between 4-23 generations old depending on growth rate. We reasoned that if RET(R114H) was a founder mutation then those with the mutation would share a haplotype on which the mutation resides. Including SNPs spanning 509.31 kb across RET from a recently obtained 500 K genome-wide dataset for a subset of 181 patients (14 RET(R114H) patients), we applied haplotype estimation methods to determine whether there were any segments shared between patients with RET(R114H) that are not present in those without the mutation or controls. Analysis yielded a 250.2 kb (51 SNP) shared segment over the RET gene (and downstream) in only those patients with the mutation with no similar segments found among other patients.
Conclusions: This suggests that RET(R114H) is a founder mutation for HSCR in the Chinese population.
Conflict of interest statement
Figures


Similar articles
-
RET polymorphisms and the risk of Hirschsprung's disease in a Chinese population.J Hum Genet. 2008;53(9):825-833. doi: 10.1007/s10038-008-0315-x. Epub 2008 Jul 8. J Hum Genet. 2008. PMID: 18612588
-
RET 3'UTR polymorphisms and its protective role in Hirschsprung disease in southeastern Chinese.J Pediatr Surg. 2012 Sep;47(9):1699-705. doi: 10.1016/j.jpedsurg.2012.03.057. J Pediatr Surg. 2012. PMID: 22974609
-
Chronic intestinal pseudo-obstruction in a child harboring a founder Hirschsprung RET mutation.Am J Med Genet A. 2016 Sep;170(9):2400-3. doi: 10.1002/ajmg.a.37787. Epub 2016 Jun 8. Am J Med Genet A. 2016. PMID: 27273837
-
Comprehensive characterization of the genetic landscape of familial Hirschsprung's disease.World J Pediatr. 2023 Jul;19(7):644-651. doi: 10.1007/s12519-023-00686-x. Epub 2023 Mar 1. World J Pediatr. 2023. PMID: 36857021 Free PMC article. Review.
-
[Molecular biology, basic research and diagnosis of Hirschsprung's disease].Pathologe. 2007 Mar;28(2):119-24. doi: 10.1007/s00292-007-0897-7. Pathologe. 2007. PMID: 17279407 Review. German.
Cited by
-
Mutations in the NRG1 gene are associated with Hirschsprung disease.Hum Genet. 2012 Jan;131(1):67-76. doi: 10.1007/s00439-011-1035-4. Epub 2011 Jun 25. Hum Genet. 2012. PMID: 21706185
-
Two founder mutations in the SEC23B gene account for the relatively high frequency of CDA II in the Italian population.Am J Hematol. 2011 Sep;86(9):727-32. doi: 10.1002/ajh.22096. Am J Hematol. 2011. PMID: 21850656 Free PMC article.
-
RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis.PLoS One. 2014 Mar 20;9(3):e90091. doi: 10.1371/journal.pone.0090091. eCollection 2014. PLoS One. 2014. PMID: 24651702 Free PMC article.
-
Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.BMC Cancer. 2021 Apr 7;21(1):369. doi: 10.1186/s12885-021-08116-9. BMC Cancer. 2021. PMID: 33827484 Free PMC article.
-
RET and NRG1 interplay in Hirschsprung disease.Hum Genet. 2013 May;132(5):591-600. doi: 10.1007/s00439-013-1272-9. Epub 2013 Feb 12. Hum Genet. 2013. PMID: 23400839
References
-
- Amiel J, Sproat-Emison E, Garcia-Barcelo M, Lantieri F, Burzynski G, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14. - PubMed
-
- Chakravarti A, Lyonnet S. Scriver CR, Sly WS, Valle D, Beaudet AL, editors. Hirschsprung Disease. The Metabolic and Molecular Basis of Inherited Diseases: McGraw-Hill: New York. 2001. pp. 6231–6255.
-
- Lyonnet S, Bolino A, Pelet A, Abel L, Nihoul-Fekete C, et al. A gene for Hirschsprung disease maps to the proximal long arm of chromosome 10. Nat Genet. 1993;4:346–350. - PubMed
-
- Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. RET-deficient mice: an animal model for Hirschsprung's disease and renal agenesis. J Intern Med. 1995;238:327–332. - PubMed
-
- Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, et al. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature. 2005;434:857–863. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources